JAK and IL-23 Inhibitors for Ulcerative Colitis: Making Decisions About Dosage

(MedPage Today) -- While JAK and interleukin (IL)-23 inhibitors have rapidly entered routine care for ulcerative colitis (UC), the ideal maintenance doses remain unclear.
"The unresolved question is: Which patient actually needs the higher maintenance...